Literature DB >> 20019051

Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Faneng Sun1, Valeria Cavalli.   

Abstract

Given the complexity of brain and nerve tissues, systematic approaches are essential to understand normal physiological conditions and functional alterations in neurological diseases. Mass spectrometry-based proteomics is increasingly used in neurosciences to determine both basic and clinical differential protein expression, protein-protein interactions, and post-translational modifications. Proteomics approaches are especially useful to understand the mechanisms of nerve regeneration and degeneration because changes in axons following injury or in disease states often occur without the contribution of transcriptional events in the cell body. Indeed, the current understanding of axonal function in health and disease emphasizes the role of proteolysis, local axonal protein synthesis, and a broad range of post-translational modifications. Deciphering how axons regenerate and degenerate has thus become a postgenomics problem, which depends in part on proteomics approaches. This review focuses on recent proteomics approaches designed to uncover the mechanisms and molecules involved in neuronal regeneration and degeneration. It emerges that the principal degenerative mechanisms converge to oxidative stress, dysfunctions of axonal transport, mitochondria, chaperones, and the ubiquitin-proteasome systems. The mechanisms regulating nerve regeneration also impinge on axonal transport, cytoskeleton, and chaperones in addition to changes in signaling pathways. We also discuss the major challenges to proteomics work in the nervous system given the complex organization of the brain and nerve tissue at the anatomical, cellular, and subcellular levels.

Entities:  

Mesh:

Year:  2009        PMID: 20019051      PMCID: PMC2871427          DOI: 10.1074/mcp.R900003-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  111 in total

1.  Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury.

Authors:  S Neumann; C J Woolf
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

2.  Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration.

Authors:  Connie R Jiménez; Floor J Stam; Ka Wan Li; Yvonne Gouwenberg; Martin P Hornshaw; Fred De Winter; Joost Verhaagen; August B Smit
Journal:  Mol Cell Proteomics       Date:  2004-10-25       Impact factor: 5.911

3.  Real time imaging of calcium-induced localized proteolytic activity after axotomy and its relation to growth cone formation.

Authors:  D Gitler; M E Spira
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

4.  Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo.

Authors:  A M Kenney; J D Kocsis
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

5.  Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis.

Authors:  Kei Fukada; Fujian Zhang; Alexis Vien; Neil R Cashman; Haining Zhu
Journal:  Mol Cell Proteomics       Date:  2004-10-21       Impact factor: 5.911

6.  Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons.

Authors:  Dianna Willis; Ka Wan Li; Jun-Qi Zheng; Jay H Chang; August B Smit; August Smit; Theresa Kelly; Tanuja T Merianda; James Sylvester; Jan van Minnen; Jeffery L Twiss
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

7.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Manuela Basso; Sabrina Giraudo; Davide Corpillo; Bruno Bergamasco; Leonardo Lopiano; Mauro Fasano
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

8.  The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.

Authors:  Weiqian Mi; Bogdan Beirowski; Thomas H Gillingwater; Robert Adalbert; Diana Wagner; Daniela Grumme; Hitoshi Osaka; Laura Conforti; Stefan Arnhold; Klaus Addicks; Keiji Wada; Richard R Ribchester; Michael P Coleman
Journal:  Brain       Date:  2005-01-11       Impact factor: 13.501

9.  Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration.

Authors:  Poonam Verma; Sabrina Chierzi; Amanda M Codd; Douglas S Campbell; Ronald L Meyer; Christine E Holt; James W Fawcett
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

10.  Sunday Driver links axonal transport to damage signaling.

Authors:  Valeria Cavalli; Pekka Kujala; Judith Klumperman; Lawrence S B Goldstein
Journal:  J Cell Biol       Date:  2005-02-28       Impact factor: 10.539

View more
  4 in total

1.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 2.  Decoding neuroproteomics: integrating the genome, translatome and functional anatomy.

Authors:  Robert R Kitchen; Joel S Rozowsky; Mark B Gerstein; Angus C Nairn
Journal:  Nat Neurosci       Date:  2014-10-28       Impact factor: 24.884

Review 3.  Clinical proteomics of enervated neurons.

Authors:  Mohor Biplab Sengupta; Arunabha Chakrabarti; Suparna Saha; Debashis Mukhopadhyay
Journal:  Clin Proteomics       Date:  2016-05-05       Impact factor: 3.988

4.  Remodeling of the Actin/Spectrin Membrane-associated Periodic Skeleton, Growth Cone Collapse and F-Actin Decrease during Axonal Degeneration.

Authors:  Nicolas Unsain; Martin D Bordenave; Gaby F Martinez; Sami Jalil; Catalina von Bilderling; Federico M Barabas; Luciano A Masullo; Aaron D Johnstone; Philip A Barker; Mariano Bisbal; Fernando D Stefani; Alfredo O Cáceres
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.